PRESS RELEASE published on 07/18/2024 at 07:30, 2 years ago Nicox Provides Second Quarter 2024 Update Nicox reports €1.6M revenue & €7.8M cash for Q2 2024, extending funds until Feb 2025. Focus on NCX 470 development & Denali trial progress. New Board members appointed Revenue Cash Position Nicox NCX 470 Denali Trial
BRIEF published on 07/16/2024 at 07:35, 2 years ago Nicox appoints Damian Marron Chairman of the Board of Directors Board Of Directors Ophthalmology Nicox Marc Le Bozec Damian Brown
PRESS RELEASE published on 07/16/2024 at 07:30, 2 years ago Nicox appoints experienced biotech leader Damian Marron as Chair of the Board and Marc Le Bozec as Director Nicox appoints Damian Marron as Chair of the Board and Marc Le Bozec as Director. Experienced leaders join Nicox Board, Labbe and Kaplan step down. Strategic shift in leadership Board Of Directors Healthcare Nicox Damian Marron Marc Le Bozec
BRIEF published on 06/19/2024 at 07:35, 2 years 1 month ago Nicox succeeds in its capital increase of 3.3 million euros Increase In Capital Ophthalmology Nicox NCX 470 Ocumension Therapeutics
BRIEF published on 06/03/2024 at 07:35, 2 years 2 months ago Nicox SA Announces Voting Rights as of May 31, 2024 Euronext Growth Paris Share Capital Voting Rights AMF Nicox
PRESS RELEASE published on 06/03/2024 at 07:30, 2 years 2 months ago Number of voting rights as of May 31, 2024 Nicox SA monthly publication of the number of shares and voting rights. Details on market, ISIN code, and company's lead programs Voting Rights Shares Ophthalmology Monthly Publication Nicox SA
BRIEF published on 05/31/2024 at 07:35, 2 years 2 months ago Nicox is hosting a webcast for its shareholders on June 6, 2024 Shareholders Webcast Increase In Capital Ophthalmology Nicox
BRIEF published on 05/24/2024 at 07:35, 2 years 2 months ago Nicox: 2024 Ordinary Shareholder Meeting Scheduled for June 28th 2024 Shareholder Meeting Voting Process Ophthalmology Nicox
PRESS RELEASE published on 05/24/2024 at 07:30, 2 years 2 months ago Nicox: 2024 Ordinary Shareholder Meeting to be held on June 28th, 2024 Nicox convenes its 2024 Ordinary Shareholder Meeting on June 28th, 2024, in Sophia Antipolis, France. Shareholders can vote in person, by proxy, or online Shareholder Voting Nicox 2024 Ordinary Shareholder Meeting June 28 2024 Ophthalmology Company
Published on 08/15/2026 at 00:50, 4 hours 18 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 4 hours 53 minutes ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 5 hours 23 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 5 hours 43 minutes ago NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 6 hours 8 minutes ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/14/2026 at 18:15, 10 hours 53 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 13 hours 2 minutes ago GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON
Published on 08/14/2026 at 15:29, 13 hours 39 minutes ago Tradegate AG publishes its half-year report
Published on 08/14/2026 at 15:02, 14 hours 5 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 08/10/2026 at 18:00, 4 days 11 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 4 days 17 hours ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 4 days 17 hours ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 4 days 19 hours ago Number of shares and voting rights - July 2026 (In French only)
